Balaji V. Kadri
Director of Formulation Development
QS Pharma (WIL Research)
Balaji V. Kadri, is currently Director of Formulation Development & Clinical Manufacturing at QS Pharma, LLC. Mr. Kadri has more than 18 years of formulation and process development experience within the contract research and generic industry. He was previously senior director of Pharmaceutical Operations at PharmaForm, where he was responsible for analytical, formulation development, and cGMP manufacturing. Prior to that, he headed the Preformulation and Formulation Development group at Xcelience, LLC for 10 years. He previously worked in formulation development and scale-up manufacturing at Apotex for six years. His broad dosage form experience includes immediate release tablets and capsules, sustained release capsules/tablets/beads, liquid/semi-solid in capsule, gels, paediatric solutions, suspensions, and parenteral. His expertise includes formulation development from preclinical to commercialization, overcoming solubilization challenges, enhancing bioavailability, taste masking, and development of controlled release dosage forms. He has authored numerous articles, presented many abstracts, is co-inventor of several patents and is a contributor of several excipient monographs in “Handbook of Pharmaceutical Excipients” 7th edition (2012). He is an active member of the American Association of Pharmaceutical Scientists (AAPS) and a registered life member in the Karnataka State Pharmacy Council in India.